However, Sirt2.1 itself is upregulated by HBx and this upregulation of Sirt2 helps in the progression of HBV-induced HCC or hepatocarcinogenesis (Cheng et al., 2018). Here, SIRT2 is linked to hepatocellular carcinoma.